BIOCRYST PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $14.82 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-02-27.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-02-27
- BIOCRYST PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-06-30 was $14.82M.
- BIOCRYST PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $14.82M, a 25.48% decline from fiscal 2019.
- BIOCRYST PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $19.88M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2020-12-31 | $14.82M 10-K · filed 2023-02-27 | |
| 2020-06-30 | $14.82M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $19.88M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |